Should we keep on? Looking into pharmacogenomics of ADHD in adulthood from a different perspective. (Q38243174)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155937 AND SRC:MED&resulttype=core&format=json

13 March 2020

title

Should we keep on? Looking into pharmacogenomics of ADHD in adulthood from a different perspective (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155937 AND SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155937 AND SRC:MED&resulttype=core&format=json

13 March 2020

Nina Roth Mota

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155937 AND SRC:MED&resulttype=core&format=json

13 March 2020

Eugenio H. Grevet

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155937 AND SRC:MED&resulttype=core&format=json

13 March 2020

Claiton H D Bau

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155937 AND SRC:MED&resulttype=core&format=json

13 March 2020

8

Verônica Contini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155937 AND SRC:MED&resulttype=core&format=json

13 March 2020

3

Bruna Santos da Silva

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155937 AND SRC:MED&resulttype=core&format=json

Marcelo Victor Wüst Zibetti

13 March 2020

5

object named as

Marcelo M Victor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155937 AND SRC:MED&resulttype=core&format=json

13 March 2020

author name string

Pricila Girardi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155937 AND SRC:MED&resulttype=core&format=json

13 March 2020

publication date

1 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155937 AND SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155937 AND SRC:MED&resulttype=core&format=json

13 March 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155937 AND SRC:MED&resulttype=core&format=json

13 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155937 AND SRC:MED&resulttype=core&format=json

13 March 2020

page(s)

1365-1381

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155937 AND SRC:MED&resulttype=core&format=json

The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies

13 March 2020

cites work

1 reference

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

21 January 2018

1 reference

The genetics of attention deficit/hyperactivity disorder in adults, a review

21 January 2018

1 reference

Developmental twin study of attention problems: high heritabilities throughout development

21 January 2018

1 reference

Molecular genetics of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

Do stimulants improve functioning in adults with ADHD? A review of the literature

21 January 2018

1 reference

Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies

21 January 2018

1 reference

Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder.

21 January 2018

1 reference

Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis

21 January 2018

1 reference

Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder

21 January 2018

1 reference

Reasons for pretreatment attrition and dropout from methylphenidate in adults with attention-deficit/hyperactivity disorder: the role of comorbidities.

21 January 2018

1 reference

Severity but not comorbidities predicts response to methylphenidate in adults with attention-deficit/hyperactivity disorder: results from a naturalistic study.

21 January 2018

1 reference

Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review.

21 January 2018

1 reference

Pharmacogenetics in psychiatry: translating research into clinical practice.

21 January 2018

1 reference

Response to methylphenidate is not influenced by DAT1 polymorphisms in a sample of Brazilian adult patients with ADHD.

21 January 2018

1 reference

Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).

21 January 2018

1 reference

Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD

21 January 2018

1 reference

The relevance of "missing heritability " in pharmacogenomics

21 January 2018

1 reference

Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders

21 January 2018

1 reference

Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder

21 January 2018

1 reference

Pharmacogenetics, pharmacogenomics and personalized medicine: are we there yet?

21 January 2018

1 reference

Inheritance and drug response

21 January 2018

1 reference

Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk

21 January 2018

1 reference

Pharmacokinetics and Clinical Effectiveness of Methylphenidate

21 January 2018

1 reference

Enantioselective pharmacokinetics and pharmacodynamics of dl-threo-methylphenidate in children with attention deficit hyperactivity disorder

21 January 2018

1 reference

Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter?

21 January 2018

1 reference

Methylphenidate is stereoselectively hydrolyzed by human carboxylesterase CES1A1.

21 January 2018

1 reference

Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis

21 January 2018

1 reference

Methylphenidate side effect profile is influenced by genetic variation in the attention-deficit/hyperactivity disorder-associated CES1 gene.

21 January 2018

1 reference

Carboxylesterase 1 gene polymorphism and methylphenidate response in ADHD.

21 January 2018

1 reference

STRING v9.1: protein-protein interaction networks, with increased coverage and integration

21 January 2018

1 reference

STITCH 4: integration of protein-chemical interactions with user data

21 January 2018

1 reference

Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 A resolution

21 January 2018

1 reference

Vesicular traffic in cell navigation.

21 January 2018

1 reference

Pharmacogenetics of methylphenidate response in preschoolers with ADHD.

21 January 2018

1 reference

A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder

21 January 2018

1 reference

Effects of methylphenidate: the cellular point of view

21 January 2018

1 reference

Prioritization of candidate genes for attention deficit hyperactivity disorder by computational analysis of multiple data sources

21 January 2018

1 reference

A high-density single-nucleotide polymorphism screen of 23 candidate genes in attention deficit hyperactivity disorder: suggesting multiple susceptibility genes among Chinese Han population

21 January 2018

1 reference

Genome-wide association scan of the time to onset of attention deficit hyperactivity disorder

21 January 2018

1 reference

Evaluation of common variants in 16 genes involved in the regulation of neurotransmitter release in ADHD.

21 January 2018

1 reference

MAOA is associated with methylphenidate improvement of oppositional symptoms in boys with attention deficit hyperactivity disorder

21 January 2018

1 reference

Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study

21 January 2018

1 reference

The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes

21 January 2018

1 reference

Role of gene-gene/gene-environment interaction in the etiology of eastern Indian ADHD probands

21 January 2018

1 reference

Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: preferential transmission of the MAO-A 941G allele to affected children

21 January 2018

1 reference

Psychopathy trait scores in adolescents with childhood ADHD: the contribution of genotypes affecting MAOA, 5HTT and COMT activity.

21 January 2018

1 reference

Linkage studies between attention-deficit hyperactivity disorder and the monoamine oxidase genes

21 January 2018

1 reference

Monoamine oxidase A gene polymorphism predicts adolescent outcome of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

Association of Positive and Negative Parenting Behavior with Childhood ADHD: Interactions with Offspring Monoamine Oxidase A (MAO-A) Genotype

21 January 2018

1 reference

Family-based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous [...]

21 January 2018

1 reference

Association analyses of MAOA in Chinese Han subjects with attention-deficit/hyperactivity disorder: family-based association test, case-control study, and quantitative traits of impulsivity

21 January 2018

1 reference

The monoamine oxidase B gene exhibits significant association to ADHD.

21 January 2018

1 reference

Neural mechanisms of attention-deficit/hyperactivity disorder symptoms are stratified by MAOA genotype

21 January 2018

1 reference

Association of a monoamine oxidase-a gene promoter polymorphism with ADHD and anxiety in boys with autism spectrum disorder

21 January 2018

1 reference

Association study between the monoamine oxidase A gene and attention deficit hyperactivity disorder in Taiwanese samples

21 January 2018

1 reference

The influence of serotonin- and other genes on impulsive behavioral aggression and cognitive impulsivity in children with attention-deficit/hyperactivity disorder (ADHD): Findings from a family-based association test (FBAT) analysis

21 January 2018

1 reference

Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB.

21 January 2018

1 reference

Alpha-synuclein and intracellular trafficking: impact on the spreading of Parkinson's disease pathology.

21 January 2018

1 reference

Synucleins: are they two-edged swords?

21 January 2018

1 reference

Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes

21 January 2018

1 reference

Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorder

21 January 2018

1 reference

Parkin increases dopamine uptake by enhancing the cell surface expression of dopamine transporter

21 January 2018

1 reference

Parkin suppresses the expression of monoamine oxidases

21 January 2018

1 reference

An association study between SNAP-25 gene and attention-deficit hyperactivity disorder

21 January 2018

1 reference

Candidate gene analysis in an on-going genome-wide association study of attention-deficit hyperactivity disorder: suggestive association signals in ADRA1A.

21 January 2018

1 reference

Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations

21 January 2018

1 reference

Evidence of association between SNAP25 gene and attention deficit hyperactivity disorder in a Latin American sample

21 January 2018

1 reference

The relationship between the presence of ADHD and certain candidate gene polymorphisms in a Turkish sample

21 January 2018

1 reference

DNA variation in the SNAP25 gene confers risk to ADHD and is associated with reduced expression in prefrontal cortex

21 January 2018

1 reference

Candidate gene studies of ADHD: a meta-analytic review

21 January 2018

1 reference

Association among SNAP-25 gene DdeI and MnlI polymorphisms and hemodynamic changes during methylphenidate use: a functional near-infrared spectroscopy study

21 January 2018

1 reference

The Correlation between Relatives on the Supposition of Mendelian Inheritance

21 January 2018

1 reference

Detecting gene-gene interactions that underlie human diseases

21 January 2018

1 reference

Interaction between FEZ1 and DISC1 in regulation of neuronal development and risk for schizophrenia

21 January 2018

1 reference

Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interaction

21 January 2018

1 reference

Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder

21 January 2018

1 reference

Interaction between genetic variants of DLGAP3 and SLC1A1 affecting the risk of atypical antipsychotics-induced obsessive-compulsive symptoms.

21 January 2018

1 reference

Gene-gene interaction analyses between NMDA receptor subunit and dopamine receptor gene variants and clozapine response.

21 January 2018

1 reference

The mystery of missing heritability: Genetic interactions create phantom heritability

21 January 2018

1 reference

A cooperative interaction between LPHN3 and 11q doubles the risk for ADHD.

21 January 2018

1 reference

Dopaminergic and noradrenergic gene polymorphisms and response to methylphenidate in korean children with attention-deficit/hyperactivity disorder: is there an interaction?

21 January 2018

1 reference

Marker gene polymorphisms in hyperkinetic disorder--predictors of clinical response to treatment with methylphenidate?

21 January 2018

1 reference

Approaching "phantom heritability" in psychiatry by hypothesis-driven gene-gene interactions.

21 January 2018

1 reference

The Meaning of Interaction

21 January 2018

1 reference

Promiscuity as a functional trait: intrinsically disordered regions as central players of interactomes

21 January 2018

1 reference

D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism.

21 January 2018

1 reference

Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor

21 January 2018

1 reference

Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans.

21 January 2018

1 reference

Dopamine D4 receptor, but not the ADHD-associated D4.7 variant, forms functional heteromers with the dopamine D2S receptor in the brain

21 January 2018

1 reference

Dopamine D2 and D4 receptor heteromerization and its allosteric receptor-receptor interactions

21 January 2018

1 reference

DRD2/DRD4 heteromerization may influence genetic susceptibility to alcohol dependence

21 January 2018

1 reference

Association between DRD2/DRD4 interaction and conduct disorder: a potential developmental pathway to alcohol dependence

21 January 2018

1 reference

A large-scale meta-analysis of the association between the ANKK1/DRD2 Taq1A polymorphism and alcohol dependence

21 January 2018

1 reference

Dopamine receptor (D4) polymorphism is related to comorbidity between marijuana abuse and depression

21 January 2018

1 reference

Distinct functions of the two isoforms of dopamine D2 receptors

21 January 2018

1 reference

Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory.

21 January 2018

1 reference

Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants

21 January 2018

1 reference

Genome-wide association study of inattention and hyperactivity-impulsivity measured as quantitative traits

21 January 2018

1 reference

Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD.

21 January 2018

1 reference

Genome-wide association study in German patients with attention deficit/hyperactivity disorder

21 January 2018

1 reference

Genome-wide association study of motor coordination problems in ADHD identifies genes for brain and muscle function

21 January 2018

1 reference

Case-Control Genome-Wide Association Study of Attention-Deficit/Hyperactivity Disorder

21 January 2018

1 reference

Meta-Analysis of Genome-Wide Association Studies of Attention-Deficit/Hyperactivity Disorder

21 January 2018

1 reference

Family-based genome-wide association scan of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

Genome-wide association scan of attention deficit hyperactivity disorder

21 January 2018

1 reference

Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

Genome-wide association study of blood pressure response to methylphenidate treatment of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

Hundreds of variants clustered in genomic loci and biological pathways affect human height

21 January 2018

1 reference

Biological, clinical and population relevance of 95 loci for blood lipids

21 January 2018

1 reference

Large-scale genotyping identifies 41 new loci associated with breast cancer risk

21 January 2018

1 reference

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

21 January 2018

1 reference

Genome-wide association analysis identifies 13 new risk loci for schizophrenia

21 January 2018

1 reference

Open-label administration of lisdexamfetamine dimesylate improves executive function impairments and symptoms of attention-deficit/hyperactivity disorder in adults

21 January 2018

1 reference

Effect of atomoxetine on executive function impairments in adults with ADHD.

21 January 2018

1 reference

Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder

21 January 2018

1 reference

Adrenergic neurotransmitter system transporter and receptor genes associated with atomoxetine response in attention-deficit hyperactivity disorder children

21 January 2018

1 reference

A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD).

21 January 2018

1 reference

ADHD pharmacogenetics across the life cycle: New findings and perspectives.

21 January 2018

1 reference

A current update on ADHD pharmacogenomics

21 January 2018

1 reference

Pharmacogenetic approach for a better drug treatment in children

21 January 2018

1 reference

Polygenic heritability estimates in pharmacogenetics: focus on asthma and related phenotypes

21 January 2018

1 reference

Practical limitations to estimating heritability in pharmacogenetic studies

21 January 2018

1 reference

Genome-wide approaches in pharmacogenomics: heritability estimation and pharmacoethnicity as primary challenges

21 January 2018

1 reference

Methylphenidate transdermal system in adult ADHD and impact on emotional and oppositional symptoms.

21 January 2018

1 reference

A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.

21 January 2018

1 reference

Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo

21 January 2018

1 reference

Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo

21 January 2018

1 reference

Is response to OROS-methylphenidate treatment moderated by treatment with antidepressants or psychiatric comorbidity? A secondary analysis from a large randomized double blind study of adults with ADHD.

21 January 2018

1 reference

Do phenotypic characteristics, parental psychopathology, family functioning, and environmental stressors have a role in the response to methylphenidate in children with attention-deficit/hyperactivity disorder? A naturalistic study from a developing

21 January 2018

1 reference

A clinical review of outcomes of the multimodal treatment study of children with attention-deficit/hyperactivity disorder (MTA).

21 January 2018

1 reference

A pilot study: differential effects of methylphenidate-OROS on working memory and attention functions in children with attention-deficit/hyperactivity disorder with and without behavioural comorbidities

21 January 2018

1 reference

Baseline severity of parent-perceived inattentiveness is predictive of the difference between subjective and objective methylphenidate responses in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

Dose-response characteristics in adolescents with attention-deficit/hyperactivity disorder treated with OROS methylphenidate in a 4-week, open-label, dose-titration study.

21 January 2018

1 reference

The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis

21 January 2018

1 reference

Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis

21 January 2018

1 reference

Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later

21 January 2018

1 reference

Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families

21 January 2018

1 reference

Pharmacogenetics of methylphenidate response in attention deficit/hyperactivity disorder: association with the dopamine transporter gene (SLC6A3).

21 January 2018

1 reference

Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD.

21 January 2018

1 reference